Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNYSE:HUM
Previous Symbol
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.45
Current Ratio1.68
Quick Ratio1.68
Price-To-Earnings
Trailing P/E Ratio26.78
Forward P/E Ratio21.81
P/E Growth1.45
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.80
Cash Flow$15.7640 per share
Price / Cash Flow19.96
Book Value$68.89 per share
Price / Book4.57
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins2.70%
Return on Equity19.10%
Return on Assets6.36%
Miscellaneous
Employees45,900
Outstanding Shares137,190,000
Market Cap$41.98 billion
OptionableOptionable
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana declared a quarterly dividend on Friday, November 2nd. Investors of record on Monday, December 31st will be given a dividend of $0.50 per share on Friday, January 25th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date is Friday, December 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana announced that its board has initiated a stock buyback plan on Friday, December 15th 2017, which allows the company to buyback $3,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company's management believes its shares are undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) issued its quarterly earnings results on Wednesday, November, 7th. The insurance provider reported $4.58 EPS for the quarter, topping the consensus estimate of $4.29 by $0.29. The insurance provider earned $14.21 billion during the quarter, compared to analysts' expectations of $13.97 billion. Humana had a net margin of 2.70% and a return on equity of 19.10%. During the same period in the previous year, the company earned $3.39 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana issued an update on its FY18 earnings guidance on Wednesday, November, 28th. The company provided earnings per share guidance of $14.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.43.
What price target have analysts set for HUM?
18 brokers have issued 12 month target prices for Humana's shares. Their predictions range from $250.00 to $418.00. On average, they anticipate Humana's stock price to reach $349.7778 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price. View Analyst Price Targets for Humana.
What is the consensus analysts' recommendation for Humana?
18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.
Has Humana been receiving favorable news coverage?
Headlines about HUM stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Humana earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned news stories about the insurance provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future.
Are investors shorting Humana?
Humana saw a increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,549,873 shares, an increase of 63.6% from the November 15th total of 2,170,421 shares. Based on an average daily volume of 1,124,142 shares, the short-interest ratio is presently 3.2 days. Approximately 2.6% of the company's shares are sold short. View Humana's Current Options Chain.
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Who are Humana's major shareholders?
Humana's stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (8.99%), BlackRock Inc. (8.94%), Vanguard Group Inc. (7.37%), Capital International Investors (5.99%), Capital Research Global Investors (2.86%) and Capital World Investors (2.45%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which institutional investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, MERIAN GLOBAL INVESTORS UK Ltd, Wells Fargo & Company MN, Mitsubishi UFJ Trust & Banking Corp, Alliancebernstein L.P., AQR Capital Management LLC, Point72 Asset Management L.P. and Ceredex Value Advisors LLC. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which institutional investors are buying Humana stock?
HUM stock was acquired by a variety of institutional investors in the last quarter, including Capital International Investors, Renaissance Technologies LLC, Ffcm LLC, Morgan Stanley, FMR LLC, Marshall Wace North America L.P., Vanguard Group Inc. and BlackRock Inc.. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $315.00.
How big of a company is Humana?
Humana has a market capitalization of $41.98 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
What is Humana's official website?
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (NYSE HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
